You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 207 No. 1, January 6, 1969 TABLE OF CONTENTS
  JAMA
 •  Online Features
ARTICLES
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of an Influenza Virus Vaccine, Bivalent (Types A2 and B)

(Zonomune)

JAMA. 1969;207(1):141.


Abstract

Influenza virus vaccine, bivalent, contains formaldehyde-inactivated influenza types A2 and B grown on chicken-egg extraembryonic fluid. Thimerosal 1:10,000 is added as a preservative. Each 0.5 ml of this vaccine currently contains a minimum of 150 chick-cell agglutination (CCA) units of each of two strains of influenza A virus (Taiwan 1/64 [A2] and Japan 170/62 [A2]) and 300 CCA units of influenza B virus (Massachusetts 3/66 [B]).



Footnotes

Scientific data on this vaccine were supplied to the Council by Eli Lilly & Co., Indianapolis.

Reprint requests to Secretary, Council on Drugs, American Medical Association, 535 N Dearborn St, Chicago 60610.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.